ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

Fraumeni Appointed field Studies Chief

January 18, 1980

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

Bonadonna, Fisher Share %50,000 Bristol-Myers Award

April 23, 1993

In Brief: Zelen To Retire As Head Of ECOG Statistical Center; NIH Organizes Genome Research Center

October 20, 1989

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997